Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

As biosimilars hit, EU pharma warns against blanket prescribing

European drugmakers, faced with increasing competition from cut-price copies of complex biotech drugs, cautioned doctors on Thursday to take care when switching patients from an established product to a so-called biosimilar version.

The complex nature of biological medicines, which are made inside living cells, means copies can never be exactly the same as the original. But a growing number of such drugs have now been approved in Europe as similar enough to do the job.

The European Medicines Agency has to date approved two dozen biosimilars against just four in the United States.

Late last month the first biosimilar cancer drug hit the European the market, with the launch of Celltrion's Truxima, a copy of Roche's blood cancer treatment Rituxan or MabThera.

Truxima has been approved in all of Rituxan/MabThera's indications and governments around Europe are keen to see it used widely, in order to curb rising drug bills.

Three industry associations representing branded drug firms, however, said in a joint statement that doctors should look at the circumstances of each individual patient before switching them from established drugs to cheaper biosimilars.

"It is vital for a physician to balance the level of evidence against the level of risk or uncertainty in each particular case," the EFPIA, EBE and IFPMA associations said.

"A 'one size fits all' approach is not appropriate."

(Reporting by Ben Hirschler; Editing by Edmund Blair)

Thu Mar 9, 2017

Source: http://www.reuters.com/


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies